CompletedNot Applicable

SMART Trial for Buprenorphine-Naloxone Medication Assisted Treatment Adherence

United States332 participantsStarted 2022-02-01

Plain-language summary

The purpose of this study is to compare the effectiveness of two different interventions for medication-assisted treatment (MAT) adherence: Contingency Management (CM) and Brief Motivational Interviewing + Substance Free Activities + Mindfulness (BSM).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Present with symptoms of Opioid Use Disorder * Eligible of receipt of buprenorphine-naloxone medication as determined by Study Doctor * Access to a telephone Exclusion Criteria: * Under 18 years old * Unable to understand spoken English

What they're measuring

Medication-Assisted Treatment (MAT) Adherence

Timeframe: through study completion, an average of 8 months

Trial details

NCT IDNCT04080180

SponsorKaren Derefinko, PhD

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-02-01

View on ClinicalTrials.gov More Opioid-use Disorder trials